Current and historical daily PE Ratio for Ipsen SA (
) from 2007 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ipsen stock (IPSEY) PE ratio as of May 15 2024 is 15.61.
More Details
Ipsen SA (IPSEY) PE Ratio (TTM) Chart
Ipsen SA (IPSEY) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Ipsen PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | 15.6 | 2024-03-12 | 13.9 |
| 2024-05-14 | 15.9 | 2024-03-11 | 13.8 |
| 2024-05-13 | 15.3 | 2024-03-08 | 13.5 |
| 2024-05-10 | 14.6 | 2024-03-07 | 13.6 |
| 2024-05-09 | 14.6 | 2024-03-06 | 13.2 |
| 2024-05-08 | 14.6 | 2024-03-05 | 13.1 |
| 2024-05-07 | 14.4 | 2024-03-04 | 13.2 |
| 2024-05-06 | 14.6 | 2024-03-01 | 13.2 |
| 2024-05-03 | 14.6 | 2024-02-29 | 13.2 |
| 2024-05-02 | 14.6 | 2024-02-28 | 13.2 |
| 2024-05-01 | 14.3 | 2024-02-27 | 13.4 |
| 2024-04-30 | 14.3 | 2024-02-26 | 13.3 |
| 2024-04-29 | 14.3 | 2024-02-23 | 13.5 |
| 2024-04-26 | 14.4 | 2024-02-22 | 13.4 |
| 2024-04-25 | 14.3 | 2024-02-21 | 13.3 |
| 2024-04-24 | 14.5 | 2024-02-20 | 13.7 |
| 2024-04-23 | 14.2 | 2024-02-16 | 13.5 |
| 2024-04-22 | 14.4 | 2024-02-15 | 13.6 |
| 2024-04-19 | 13.7 | 2024-02-14 | 13.2 |
| 2024-04-18 | 13.7 | 2024-02-13 | 13.4 |
| 2024-04-17 | 13.6 | 2024-02-12 | 13.6 |
| 2024-04-16 | 13.6 | 2024-02-09 | 13.6 |
| 2024-04-15 | 13.9 | 2024-02-08 | 13.5 |
| 2024-04-12 | 13.9 | 2024-02-07 | 13.9 |
| 2024-04-11 | 13.9 | 2024-02-06 | 13.4 |
| 2024-04-10 | 14.2 | 2024-02-05 | 13.3 |
| 2024-04-09 | 14.2 | 2024-02-02 | 13.7 |
| 2024-04-08 | 14.1 | 2024-02-01 | 13.7 |
| 2024-04-05 | 14.0 | 2024-01-31 | 13.8 |
| 2024-04-04 | 14.1 | 2024-01-30 | 13.8 |
| 2024-04-03 | 13.6 | 2024-01-29 | 13.8 |
| 2024-04-02 | 13.6 | 2024-01-26 | 14.1 |
| 2024-04-01 | 14.4 | 2024-01-25 | 13.4 |
| 2024-03-28 | 14.2 | 2024-01-24 | 13.4 |
| 2024-03-27 | 14.0 | 2024-01-23 | 13.4 |
| 2024-03-26 | 14.2 | 2024-01-22 | 13.9 |
| 2024-03-25 | 14.2 | 2024-01-19 | 13.6 |
| 2024-03-22 | 14.1 | 2024-01-18 | 13.6 |
| 2024-03-21 | 13.9 | 2024-01-17 | 13.6 |
| 2024-03-20 | 13.4 | 2024-01-16 | 13.6 |
| 2024-03-19 | 13.4 | 2024-01-12 | 13.6 |
| 2024-03-18 | 13.7 | 2024-01-11 | 13.5 |
| 2024-03-15 | 14.0 | 2024-01-10 | 14.1 |
| 2024-03-14 | 14.0 | 2024-01-09 | 14.0 |
| 2024-03-13 | 13.9 | 2024-01-08 | 14.2 |
Ipsen SA (IPSEY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Ipsen SA
NAICS : 325412
ISIN : US4626292050
Share Class Description:
IPSEY: ADRCompare
Compare
Traded in other countries / regions
IPN.France0MH6.UKIPSEY.USAIPN.AustriaI7G.GermanyIPN.Mexico IPO Date
2007-08-14Description
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers